Assieh Saadatpour is Associate Director of Biomarker Analytics for the Lung Cancer Initiative at Johnson and Johnson. Her team harnesses the power of computational genomics and data science to help discover novel biomarkers and identify cancer patient populations that best respond to different therapies. Before joining J&J, Assieh was an Associate Principal Scientist at Merck Research Lab where she led and supported immuno-oncology projects at different stages of drug discovery and development. Prior to joining pharmaceutical industry, she was a Research Fellow at Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health working on single cell genomics area. Assieh holds a Ph.D. in Mathematics and a Ph.D. Minor in Computational Science from Penn State University. She is passionate about utilizing computational approaches and analytics methods and collaborating with cross functional teams to help understand mechanisms of drug resistance and support the development of new biomarkers for use in cancer therapy.